Submited on: 19 Dec 2011 01:04:37 PM GMT
Published on: 19 Dec 2011 03:32:03 PM GMT
 

1 Is the subject of the article within the scope of the subject category? Yes
2 Are the interpretations / conclusions sound and justified by the data? Yes
3 Is this a new and original contribution? No
4 Does this paper exemplify an awareness of other research on the topic? Yes
5 Are structure and length satisfactory? Yes
6 Can you suggest brief additions or amendments or an introductory statement that will increase the value of this paper for an international audience? Yes
7 Can you suggest any reductions in the paper, or deletions of parts? No
8 Is the quality of the diction satisfactory? Yes
9 Are the illustrations and tables necessary and acceptable? Yes
10 Are the references adequate and are they all necessary? No
11 Are the keywords and abstract or summary informative? Yes
  • Other Comments:
    The manuscript has 3 important misconceptions:
    1. The internationally accepted treatment is based on 4 drugs and is not nonoterapia as mentioned in the "Discussion".
    2. The anti-tuberculosis treatment should never be suspended, as mentioned in the "Conclusion".
    3. If there is co-infection with tuberculosis and HIV, tuberculosis is treated first and then the HIV, so the drugs do not interact with each other, as mentioned in the "Conclusion".
    On the other hand, lacks the year in one of the references and they are outdated, missing in 2011.
     
  • Competing interests:
    No
  • Invited by the author to review this article? :
    No
  • Have you previously published on this or a similar topic?:
    No
  • References:
    None
  • Experience and credentials in the specific area of science:
    Although I have worked with TB for 15 years, I've never worked experimentally with drugs.
  • How to cite:  Garcia G .Management of side effects and drug interactions of anti-mycobacterial in tuberculosis. [Review of the article 'Management of Side Effects and Drug Interactions of Anti-mycobacterial in Tuberculosis ' by Mohd Thambrin F].WebmedCentral 2011;2(12):WMCRW001284
1 2 3 4 5 6 7 8 9
Report abuse